IACH Roundtable Debate- Transplant at 65+: A Still Valid Strategy or a Risk We Should Retire?
Healthcare4/7/2025 4:00 PM
Join IACH's webinar on transplant strategy for seniors. Explore survival vs. quality of life with leading experts. Learn more on WebinarCafe.
Healthcare Webinar Benefits
As part of the newly launched IACH Multiple Myeloma Academy, this high-stakes roundtable debate will challenge conventional thinking on autologous hematopoietic cell transplantation (HCT) in patients aged 65 to 70. With evolving therapies and shifting survival paradigms, should HCT remain the gold standard, or are we clinging to outdated dogma? Leading experts will go head-to-head on patient selection, survival vs. quality of life, and the rise of alternative treatments. Expect bold arguments, controversial takes, and audience engagement in this must-attend debate!
Speakers:
• Meral Beksac
• Meletios Athanasios Dimopoulos
• Maria Victoria Mateos Manteca
• Cesar Rodriguez
• Facon Thierry
• Mohamad Mohty
Comments
Publisher
International Academy for Clinical Hematology (IACH)
The International Academy for Clinical Hematology (IACH) is founded by an international group of physicians whose focus is to promote good clinical practice in the field of clinical hematology. There is a growing and urgent global demand for academic continuing education of hematologists comprising clinical skills for patient management, standardization of real-life treatment procedures, as well in the performance of routine and comprehensive care in the various fields of hematology.